Arch Therapeutics Inc (ARTH)

[Regis999]

I would guess most of you have sold by this time.

Closure Medical was acquired by JNJ in 2005 for $ 370 million.

On a FULLY DILUTED Basis $ARTH is $ 155 million. That is 42% of the $370 million. $ARTH is way beyond Closure.

JNJ and Baxter control 87% of the hemostasis market.


JNJ acquisition of Closure

http://files.shareholder.com/downloads/JNJ/0x0x51855/55e9c27d-61d0-4001-8eab-386a950a16a7/JNJ_News_2005_3_4_Financial_Releases.pdf

“Being a shareholder in this company, is like watching a cartoon character that begins riding on a go cart and after a minute of animated vehicle morphing he is riding in a Silver Shadow Rolls Royce.”